首页> 外文期刊>Ophthalmology >Primary phacoemulsification and intraocular lens implantation for acute angle-closure glaucoma.
【24h】

Primary phacoemulsification and intraocular lens implantation for acute angle-closure glaucoma.

机译:原发性超声乳化和人工晶状体植入治疗急性闭角型青光眼。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate the safety and efficacy of primary phacoemulsification and intraocular lens implantation (PPI) for acute angle-closure glaucoma (ACG). STUDY DESIGN: Prospective, nonrandomized comparative trial. PARTICIPANTS AND INTERVENTION: Forty-three eyes of 43 patients with acute ACG and uncontrolled intraocular pressure (IOP) were treated by PPI. Thirty-two eyes of 32 patients treated by conventional surgical iridectomy (CSI) constituted the control group. MAIN OUTCOME MEASURES: Postoperative visual acuity, IOP, number of antiglaucoma medications, complications, and secondary surgical interventions, if any, required for IOP control. RESULTS: Glaucoma control was achieved in 31 eyes (72%) in the PPI group and in 11 (35%) in the CSI group (P = 0.01). Mean preoperative IOP was 40.5 +/- 7.6 mmHg (standard deviation) and 39.7 +/- 7.8 mmHg, respectively (P = 0.46). Mean postoperative IOP was 17.8 +/- 3.4 mmHg (PPI group) and 20.1 +/- 4.2 mmHg (CSI group) after a mean follow-up of 10.2 +/- 3.4 months (P = 0.03). Postoperatively, the mean number of ocular hypotensive medications was 0.18 +/- 0.45 (PPI group) and 0.45 +/- 0.62 (CSI group) (P = 0.0001). Relative increase in postoperative best-corrected visual acuity (logarithm of the minimum angle of resolution) was 0.52 +/- 0.29 (PPI group) and 0.19 +/- 0.21 (CSI group), respectively (P = 0.0001). Additional surgery was necessary in 5 eyes (11.5%) in the PPI group and in 20 eyes (63%) in the CSI group (P = 0.01). Intraoperative and postoperative complications were few and manageable. CONCLUSIONS: CSI in patients with acute ACG was effective in reducing IOP initially but was associated with multiple surgical reinterventions. Conversely, primary PPI turned out to be safe and effective in reducing IOP and improving visual acuity. These results affirm that lens extraction may be considered the better procedure in uncontrolled ACG when faced with options of CSI or PPI.
机译:目的:评估初次超声乳化和人工晶状体植入术(PPI)治疗急性闭角型青光眼(ACG)的安全性和有效性。研究设计:前瞻性,非随机比较试验。参与者和干预:43例急性ACG且眼压不受控制的患者的43眼接受了PPI治疗。常规虹膜切除术(CSI)治疗的32例患者中的32只眼为对照组。主要观察指标:术后视力,IOP,抗青光眼药物的使用数量,并发症和IOP控制所需的二次手术干预(如果有)。结果:PPI组的31只眼(72%)和CSI组的11只眼(35%)实现了青光眼控制(P = 0.01)。术前平均眼压分别为40.5 +/- 7.6 mmHg(标准偏差)和39.7 +/- 7.8 mmHg(P = 0.46)。在平均随访10.2 +/- 3.4个月后,平均术后IOP为17.8 +/- 3.4 mmHg(PPI组)和20.1 +/- 4.2 mmHg(CSI组)(P = 0.03)。术后眼压降压药物的平均数为0.18 +/- 0.45(PPI组)和0.45 +/- 0.62(CSI组)(P = 0.0001)。术后最佳矫正视力(最小分辨角的对数)的相对增加分别为0.52 +/- 0.29(PPI组)和0.19 +/- 0.21(CSI组)(P = 0.0001)。 PPI组5眼(11.5%)和CSI组20眼(63%)需要额外的手术(P = 0.01)。术中和术后并发症少且可控。结论:急性ACG患者的CSI最初可有效降低IOP,但与多次外科手术再介入有关。相反,事实证明,初级PPI在减少IOP和改善视敏度方面是安全有效的。这些结果证实,面对CSI或PPI选项时,在不受控制的ACG中晶状体摘出可能被认为是更好的手术方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号